| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaccinex, Inc. (VCNX) has 0 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. VCNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2020 | Friedberg Albert | Director, 10% Owner | Buy | 982,318 | $5.09 | $4,999,998.62 | +14.8% | |
| Jan 23, 2020 | Zauderer Maurice | President And CEO | Buy | 98,231 | $5.09 | $499,995.79 | +9.8% | |
| Jan 23, 2020 | Frieberg Jacob B. | Director | Buy | 39,292 | $5.09 | $199,996.28 | New | |
| Jul 30, 2019 | Friedberg Albert | Director, 10% Owner | Buy | 1,838,235 | $4.08 | $7,499,998.80 | +38.5% | |
| Jul 30, 2019 | Zauderer Maurice | President And CEO | Buy | 183,824 | $4.08 | $750,001.92 | +22.5% | |
| Jul 26, 2019 | Friedberg Albert | Director, 10% Owner | Buy | 1,052 | $3.99 | $4,197.48 | - | |
| Mar 15, 2019 | Friedberg Albert | Director, 10% Owner | Buy | 2,000 | $3.98 | $7,960.00 | - | |
| Mar 15, 2019 | Friedberg Albert | Director, 10% Owner | Buy | 2,000 | $3.98 | $7,960.00 | - | |
| Feb 7, 2019 | Royer Scott E. | Chief Financial Officer | Buy | 2,000 | $4.98 | $9,968.00 | +46.8% | |
| Jan 15, 2019 | Royer Scott E. | Chief Financial Officer | Buy | 1,688 | $4.31 | $7,275.28 | +542.8% |